Adicet Bio to Participate in Upcoming Investor Conferences
August 02, 2021 at 07:00 AM EDT
MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in three upcoming virtual investor conferences in August.
Details of the events are as follows:
The BTIG Virtual Biotechnology Conference 2021, August 9-10, 2021
Wedbush PacGrow Healthcare Conference 2021, August 10-11, 2021
Canaccord Genuity 41st Annual Growth Conference, August 10-12, 2021
A live audio webcast of the Canaccord Genuity fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.
About Adicet Bio, Inc.
Adicet Bio., Inc.